GB8601389D0 - Treating pharmaceutical dosage forms - Google Patents
Treating pharmaceutical dosage formsInfo
- Publication number
- GB8601389D0 GB8601389D0 GB868601389A GB8601389A GB8601389D0 GB 8601389 D0 GB8601389 D0 GB 8601389D0 GB 868601389 A GB868601389 A GB 868601389A GB 8601389 A GB8601389 A GB 8601389A GB 8601389 D0 GB8601389 D0 GB 8601389D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- dosage forms
- pharmaceutical dosage
- treating pharmaceutical
- treating
- forms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002552 dosage form Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69694585A | 1985-01-30 | 1985-01-30 | |
US06/696,955 US4600645A (en) | 1985-01-31 | 1985-01-31 | Process for treating dosage forms |
Publications (2)
Publication Number | Publication Date |
---|---|
GB8601389D0 true GB8601389D0 (en) | 1986-02-26 |
GB2170104A GB2170104A (en) | 1986-07-30 |
Family
ID=27105903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08601389A Withdrawn GB2170104A (en) | 1985-01-30 | 1986-01-21 | Coated pharmaceutical dosage forms |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2170104A (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU85943A1 (en) * | 1985-06-12 | 1987-01-13 | Galephar | PHARMACEUTICAL TABLETS FOR THE EASY ADMINISTRATION OF PELLETS, THEIR PREPARATION AND THEIR USE |
US4931285A (en) * | 1988-04-28 | 1990-06-05 | Alza Corporation | Aqueous based pharmaceutical coating composition for dosage forms |
US5683719A (en) * | 1990-11-22 | 1997-11-04 | British Technology Group Limited | Controlled release compositions |
GB9025372D0 (en) * | 1990-11-22 | 1991-01-09 | Nat Res Dev | Pharmaceutical dosage forms |
JPH06504276A (en) * | 1991-01-03 | 1994-05-19 | グラクソ、カナダ、インコーポレーテッド | Manufacturing method for solid preparations |
US5958459A (en) * | 1991-12-24 | 1999-09-28 | Purdue Pharma L.P. | Opioid formulations having extended controlled released |
US5273760A (en) * | 1991-12-24 | 1993-12-28 | Euroceltigue, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
US5472712A (en) * | 1991-12-24 | 1995-12-05 | Euroceltique, S.A. | Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
US5681585A (en) * | 1991-12-24 | 1997-10-28 | Euro-Celtique, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
US7740881B1 (en) | 1993-07-01 | 2010-06-22 | Purdue Pharma Lp | Method of treating humans with opioid formulations having extended controlled release |
IL110014A (en) | 1993-07-01 | 1999-11-30 | Euro Celtique Sa | Solid controlled-release oral dosage forms of opioid analgesics |
WO1999001111A1 (en) | 1997-07-02 | 1999-01-14 | Euro-Celtique, S.A. | Stabilized sustained release tramadol formulations |
ES2221370T3 (en) | 1998-04-03 | 2004-12-16 | Egalet A/S | COMPOSITION OF CONTROLLED RELEASE. |
RU2230556C2 (en) | 1999-10-29 | 2004-06-20 | Эро-Селтик, С.А. | Hydrocodon preparative sustained-release formulations |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
WO2002036099A1 (en) | 2000-10-30 | 2002-05-10 | Euro-Celtique S.A. | Controlled release hydrocodone formulations |
US20110104214A1 (en) | 2004-04-15 | 2011-05-05 | Purdue Pharma L.P. | Once-a-day oxycodone formulations |
UA81224C2 (en) | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Dosage form of oxycodone and use thereof |
US20040253310A1 (en) | 2001-09-21 | 2004-12-16 | Gina Fischer | Morphine polymer release system |
US20040234602A1 (en) | 2001-09-21 | 2004-11-25 | Gina Fischer | Polymer release system |
US20040151772A1 (en) | 2002-11-08 | 2004-08-05 | Egalet A/S | Controlled release carvedilol compositions |
ES2360102T3 (en) | 2003-03-26 | 2011-05-31 | Egalet A/S | SYSTEM FOR CONTROLLED RELEASE OF MORPHINE. |
JP4989217B2 (en) | 2003-03-26 | 2012-08-01 | エガレット エイ/エス | Matrix composition for controlled delivery of drug substance |
US8821928B2 (en) | 2007-06-04 | 2014-09-02 | Egalet Ltd. | Controlled release pharmaceutical compositions for prolonged effect |
NZ594207A (en) | 2009-02-06 | 2013-03-28 | Egalet Ltd | Immediate release composition resistant to abuse by intake of alcohol |
NZ603579A (en) | 2009-06-24 | 2014-02-28 | Egalet Ltd | Controlled release formulations |
JP2015521988A (en) | 2012-07-06 | 2015-08-03 | イガレット・リミテッド | Abuse-preventing pharmaceutical composition for controlled release |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3242051A (en) * | 1958-12-22 | 1966-03-22 | Ncr Co | Coating by phase separation |
US3487138A (en) * | 1966-11-23 | 1969-12-30 | Merck & Co Inc | Process for preparing a delayed release medicinal tablet |
IE55745B1 (en) * | 1983-04-06 | 1991-01-02 | Elan Corp Plc | Sustained absorption pharmaceutical composition |
PH18946A (en) * | 1983-04-21 | 1985-11-14 | Elan Corp Plc | Controlled absorption pharmaceutical composition |
-
1986
- 1986-01-21 GB GB08601389A patent/GB2170104A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2170104A (en) | 1986-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8601389D0 (en) | Treating pharmaceutical dosage forms | |
PH22751A (en) | Process for treating dosage forms | |
GB2210266B (en) | Dosage form | |
GB8608149D0 (en) | Furazolidine dosage form | |
GB8626894D0 (en) | Dosage device | |
PT83075A (en) | Pharmaceutical dosage unit | |
GB8615043D0 (en) | Solid stable dosage forms | |
DE3565468D1 (en) | Drug administering apparatus | |
GB8513369D0 (en) | Treatment | |
GB8515845D0 (en) | Treatment | |
GB8501488D0 (en) | Treatment | |
GB8607178D0 (en) | Dosage means | |
ZA86252B (en) | Coated dosage forms | |
GB8708225D0 (en) | Dosage form | |
GB2171305B (en) | Pharmaceutical combinations | |
GB8620716D0 (en) | Medicament | |
ZA87111B (en) | Pharmaceutical dosage form | |
GB8513367D0 (en) | Treatment | |
GB8509039D0 (en) | Treatment | |
IE851153L (en) | Transdermal dosage form | |
IE861995L (en) | Pharmaceutical dosage unit | |
IE853321L (en) | Process for treating dosage forms | |
IE883718L (en) | Pharmaceutical dosage units for treating climacteric¹complaints | |
GB8529502D0 (en) | Pharmaceutical mixtures | |
GB8509889D0 (en) | Pharmaceutical mixtures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |